These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3096321)

  • 1. alpha-Difluoromethylornithine induces differentiation of a human embryonal carcinoma cell line in vitro.
    Uhl L; Kelly M; Schindler J
    Biochem Biophys Res Commun; 1986 Oct; 140(1):66-73. PubMed ID: 3096321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The response of several murine embryonal carcinoma cell lines to stimulation of differentiation by alpha-difluoromethylornithine.
    Schindler J; Kelly M; McCann PP
    J Cell Physiol; 1985 Jan; 122(1):1-6. PubMed ID: 3917438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ornithine decarboxylase induces embryonal carcinoma cell differentiation.
    Schindler J; Kelly M; McCann PP
    Biochem Biophys Res Commun; 1983 Jul; 114(1):410-7. PubMed ID: 6411082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of F9 embryonal carcinoma cell differentiation by inhibition of polyamine synthesis.
    Oredsson SM; Billgren M; Heby O
    Eur J Cell Biol; 1985 Sep; 38(2):335-43. PubMed ID: 3930245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of c-jun, but not retinoic acid receptor beta, is associated with F9 teratocarcinoma stem cell differentiation induced by polyamine depletion.
    Bjersing JL; Brorsson A; Heby O
    J Cell Biochem; 1997 Dec; 67(3):378-85. PubMed ID: 9361192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in polyamine metabolism during embryonal carcinoma cell differentiation in vitro.
    Kelly M; McCann PP; Schindler J
    Dev Biol; 1985 Oct; 111(2):510-4. PubMed ID: 3930315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual proliferative capacity in F9 teratocarcinoma stem cell cultures treated with alpha-difluoromethylornithine, an inducer of parietal endoderm differentiation.
    Wallon M; Holm I; Thorsson L; Oredsson SM; Heby O
    Cancer Lett; 1990 Apr; 50(2):103-7. PubMed ID: 2109649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics.
    Blank RS; Swartz EA; Thompson MM; Olson EN; Owens GK
    Circ Res; 1995 May; 76(5):742-9. PubMed ID: 7728990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
    Damjanov I; Horvat B; Gibas Z
    Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro.
    Andrews PW
    Dev Biol; 1984 Jun; 103(2):285-93. PubMed ID: 6144603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in protein synthetic profiles during retinoic-acid induction of differentiation of murine embryonal carcinoma cells.
    Schindler J; Sherman MI
    Differentiation; 1984; 28(1):78-85. PubMed ID: 6083892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein composition of the nuclear matrix of murine P19 embryonal carcinoma cells is differentiation-stage dependent.
    Stuurman N; Van Driel R; De Jong L; Meijne AM; Van Renswoude J
    Exp Cell Res; 1989 Feb; 180(2):460-6. PubMed ID: 2914580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of embryonal carcinoma cells: commitment, reversibility, and refractoriness.
    Sherman MI
    Curr Top Dev Biol; 1986; 20():345-56. PubMed ID: 3514143
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of human embryonal carcinoma cell differentiation using N,N'-hexamethylene bisacetamide in vitro.
    Sekiya S; Kimura H; Yamazawa K; Kera K; Kawata M; Takamizawa H; Oda K
    Gynecol Oncol; 1990 Jan; 36(1):69-78. PubMed ID: 2295455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
    Bahrami AR; Matin MM; Andrews PW
    Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells.
    Heim KC; White KA; Deng D; Tomlinson CR; Moore JH; Freemantle SJ; Spinella MJ
    Mol Cancer; 2007 Sep; 6():57. PubMed ID: 17880687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell cycle, cell death, and cell morphology during retinoic acid-induced differentiation of embryonal carcinoma cells.
    Mummery CL; van den Brink CE; van der Saag PT; de Laat SW
    Dev Biol; 1984 Aug; 104(2):297-307. PubMed ID: 6745486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cis-platinum on embryonal carcinoma cell lines in vitro.
    Oosterhuis JW; Andrews PW; Knowles BB; Damjanov I
    Int J Cancer; 1984 Jul; 34(1):133-9. PubMed ID: 6540246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle analysis during retinoic acid induced differentiation of a human embryonal carcinoma-derived cell line.
    Mummery CL; van Rooijen MA; van den Brink SE; de Laat SW
    Cell Differ; 1987 Mar; 20(2-3):153-60. PubMed ID: 3568136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of embryonal carcinoma cells to retinoic acid depends on colony size.
    Koopman P; Cotton RG
    Differentiation; 1986; 31(1):55-60. PubMed ID: 3732659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.